
Tesla, IREN, and Constellation Energy are the three Energy stocks to watch today, according to MarketBeat’s stock screener tool. Energy stocks are shares of companies involved in producing, refining, transporting, or supplying energy, such as oil, natural gas, coal, and increasingly renewable power. For stock market investors, these stocks represent a way to gain exposure to the energy sector, and their performance is often influenced by commodity prices, global demand, regulation, and geopolitical events. These companies had the highest dollar trading volume of any Energy stocks within the last several days.
Tesla (TSLA)
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services.
IREN (IREN)
IREN Limited, formerly known as Iris Energy Limited, owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia.
Read Our Latest Research Report on IREN
Constellation Energy (CEG)
Constellation Energy Corporation generates and sells electricity in the United States. It operates through five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions. The company sells natural gas, energy-related products, and sustainable solutions. It has approximately 33,094 megawatts of generating capacity consisting of nuclear, wind, solar, natural gas, and hydroelectric assets.
Read Our Latest Research Report on CEG
Further Reading
- MarketBeat’s Top Five Stocks to Own in June 2026
- The Speed of Light: 5 Stocks Powering AI’s Optical Future
- Dollar General Signals Reversal With 60% Rebound Potential
- Kohl’s Stock Soars After Better-Than-Feared Quarter
- Credo Technologies Paved a Path to a $300 Price Point
- Eli Lilly Wins Back CVS Health, Reverting Novo’s Advantage
